Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 625.00 | 303.79 | 425.00 | 729.75 | 0.5824 | 0.3042 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 625.00 | 303.79 | 387.00 | 729.75 | 0.5303 | 0.2110 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 604.00 | 729.75 | 0.8277 | 0.7221 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 516.00 | 729.75 | 0.7071 | 0.5205 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1551.00 | 1826.25 | 0.8493 | 0.7671 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1765.00 | 1826.25 | 0.9665 | 0.9490 | |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 1250.00 | 731.83 | 854.00 | 1826.25 | 0.4676 | 0.1241 |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1960.00 | 1826.25 | 1.0732 | 1.1101 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1948.00 | 1826.25 | 1.0667 | 1.1003 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 1250.00 | 731.83 | 1100.00 | 1826.25 | 0.6023 | 0.3619 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 1250.00 | 731.83 | 2122.00 | 1826.25 | 1.1619 | 1.2410 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 1250.00 | 731.83 | 1889.00 | 1826.25 | 1.0344 | 1.0519 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 1250.00 | 731.83 | 1899.00 | 1826.25 | 1.0398 | 1.0601 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 1250.00 | 731.83 | 2222.00 | 1826.25 | 1.2167 | 1.3206 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 1250.00 | 731.83 | 1911.00 | 1826.25 | 1.0464 | 1.0700 |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1815.00 | 1826.25 | 0.9938 | 0.9907 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 1250.00 | 731.83 | 1954.00 | 1826.25 | 1.0700 | 1.1052 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 1250.00 | 731.83 | 1865.00 | 1826.25 | 1.0212 | 1.0321 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 1250.00 | 731.83 | 2412.00 | 1826.25 | 1.3207 | 1.4695 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 1250.00 | 731.83 | 2043.00 | 1826.25 | 1.1187 | 1.1775 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 1250.00 | 731.83 | 1901.00 | 1826.25 | 1.0409 | 1.0617 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 1250.00 | 731.83 | 1871.00 | 1826.25 | 1.0245 | 1.0370 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 1250.00 | 731.83 | 1924.00 | 1826.25 | 1.0535 | 1.0806 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 1250.00 | 731.83 | 2056.00 | 1826.25 | 1.1258 | 1.1880 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 1250.00 | 731.83 | 1914.00 | 1826.25 | 1.0480 | 1.0724 |